Implications of Selection Bias Due to Delayed Study Entry in Clinical Genomic Studies
Samantha Brown, Jessica A. Lavery, Ronglai Shen, Axel Martin et autres
IMPORTANCE: Real-world data sets that combine clinical and genomic data may be subject to left truncation (when potential study participants are not included because they have already passed the milestone of interest at the time of study recruitment). The lapse between diagnosis …
us, ca (code pays fourni par la source)
53 citations
JAMA Oncology